
Medical News

New stem cell therapy to treat patients with blood cancers
EMA, 20 June 2025 Zemcelpro provides an option for patients with blood cancer who need a blood stem cell transplant and have no suitable donor

The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19
Frontiers in Immunology, 17/06/2025 A new original study published in Frontiers in Immunology (Volume 16, 2025) reports preliminary findings on the safety and efficacy of

Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol
BMJ,05/06/2025 A pioneering clinical trial – the ALLO Trial – is currently being conducted at Monash Children’s Hospital to evaluate the safety and feasibility of

Cord Blood Banking Starts to Live Up to its Promise
Parent’s Guide to Cord Blood, June 2025 Back Story of Cell Therapy for Pediatric Neurodevelopment Disorders Since 2005, cells from cord blood or umbilical cord

Australia Allows Umbilical Cord Blood Therapy for Cerebral Palsy
Parent’s Guide to Cord Blood, June 2025 Zara was the first child in Australia to receive cord blood therapy for cerebral palsy outside of a

New stem cell therapy to treat patients with blood cancers
EMA, 20 June 2025 Zemcelpro provides an option for patients with blood cancer who need a blood stem cell transplant and have no suitable donor

Optimized Gmp-Grade Wharton’s Jelly’s Mesenchymal Stromal Cells Manufacturing and Administration Protocol for Graft Versus Host Disease Prevention
SSRN, 20 May 2025 Mesenchymal stromal cells derived from Wharton’s jelly (WJ-MSCs) are multipotent cells originating from the umbilical cord, possessing strong immunomodulatory properties. These

Pooling umbilical cord-mesenchymal stromal cells derived from selected multiple donors reduces donor-dependent variability and improves their immunomodulatory properties
Stem Cell Research & Therapy, 20/05/2025 A groundbreaking study published by Miryam Mebarki and colleagues in the journal Stem Cell Research & Therapy has demonstrated

hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial
Pubmed Central, May 15, 2025 A double-blind randomized clinical trial conducted by Zhaojuan Hou and colleagues at Xiangya Hospital, Central South University, evaluated the efficacy

How Can the Placenta Help Us Understand Cancer?
The Scientist, May 14, 2025 Like cancer, placental cells multiply rapidly, invade tissues, and evade destruction by the immune system, but maternal biology somehow keeps
